Advanced search×

Journal of Clinical Rheumatology

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Ovid from 2001, LWW, Proquest, and CSA

  1. Basic science for the clinician 47[corrected]: Fcgamma receptors.

    Journal of Clinical Rheumatology 13(6):355 (2007) PMID 18176149

    It is said that a gun has only one "business end" but not so for antibodies. The end with the antigen binding sites (the Fab) certainly has gained a great deal of deserved attention; this is, after all, where the humoral immune system uses its much vaunted "antigen specificity" to engage the out...
  2. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort.

    Journal of Clinical Rheumatology 13(6):350 (2007) PMID 18176147

  3. Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapy.

    Journal of Clinical Rheumatology 13(6):361 (2007) PMID 18176152

  4. Thyroid acropachy.

    Journal of Clinical Rheumatology 13(6):360 (2007) PMID 18176151

  5. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.

    Journal of Clinical Rheumatology 13(6):313 (2007) PMID 18176138

    Protein-losing enteropathy (PLE) is an unusual manifestation of systemic lupus erythematosus (SLE), so its clinical manifestations and management are not well understood. In this study, we try to characterize the basic clinical features and the management of PLE by retrospectively analyzing the ...
  6. MELAS masquerading as a systemic vasculitis.

    Journal of Clinical Rheumatology 13(6):334 (2007) PMID 18176143

    Mitochondrial encephalomyopathy, lactic acidosis, and stroke (MELAS) is a mitochondrial genetic disorder caused by a point mutation, resulting in the substitution of guanine for adenine at nucleotide 3243 (A3243G). It is a multisystem disorder with variable manifestations and typically presents ...
  7. STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy.

    Journal of Clinical Rheumatology 13(6):341 (2007) PMID 18176145

    Successful management of the idiopathic inflammatory myopathies requires an early and accurate diagnosis. The muscle biopsy remains the definitive test. However, false-negative biopsy results are common, as the disease is typically patchy in distribution. The advent of short tau inversion recove...
  8. Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis.

    Journal of Clinical Rheumatology 13(6):307 (2007) PMID 18176137

    Increased risks of morbidity and mortality from cardiovascular (CV) events are reported in patients with rheumatoid arthritis (RA). Recent reviews recommend aggressive treatment of modifiable CV risk factors, including systemic hypertension (HTN). We examined possible contributory factors influe...
  9. A strategic approach to managed care contracting.

    Journal of Clinical Rheumatology 13(6):346 (2007) PMID 18176146

  10. Toe necrosis and acute myocardial infarction precipitated by a pheochromocytoma in a patient with systemic sclerosis.

    Journal of Clinical Rheumatology 13(6):331 (2007) PMID 18176142

    Systemic sclerosis (SSc) patients typically experience Raynaud phenomena that is often complicated by digital ischemic lesions, gangrene, and digital loss. Other causes of peripheral ischemia, such as atherosclerosis, cryoglobulinemia, antiphospholipid syndrome, myeloproliferative disorders, par...